Article
A novel caveolin-1 biomarker for clinical outcome of sarcopenia.
In vivo (Athens, Greece) - 1 Jan 2000
Lin Chih-Hsueh, Lin Cheng-Chieh, Tsai Chia-Wen, Chang Wen-Shin, Yang Mei-Do, Bau Da-Tian
Abstract excerpt
Sarcopenia, defined by the European Working Group on Sarcopenia in Older People as leading to significantly decreased muscle mass and function, contributes to increased risk of adverse health outcomes among older people. Caveolin-1 (CAV1) is a main structural protein playing a regulatory role in signaling pathways and muscle normality. However, the role of CAV1 in the development of sarcopenia is largely unknown....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
